India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine
BENGALURU, Aug 5 (Reuters) - India's Panacea Biotec Ltd PNCA.NS said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V COVID-19 vaccine using the drug substance made by Russia's Generium.
Panacea will then supply the doses to drugmaker Dr. Reddy's Laboratories REDY.NS for distribution in India. (https://bit.ly/3joeloz)
(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Shailesh Kuber)
((AnuronKumar.Mitra@thomsonreuters.com; +91 99863 58469;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.